Biodexa Pharmaceuticals ( (BDRX) ) has provided an update. Spark’s Take on BDRX Stock According to Spark, TipRanks’ AI Analyst, BDRX is a Neutral. Overall score is held down mainly by weak financial performance (no revenue, ongoing losses, and continued cash burn)…
OTTAWA – Cleveland-Cliffs Inc. CEO Lourenco Goncalves stands by its job compliance, despite layoffs at steelmaker Stelco, and requested a meeting with Industry Minister Mélanie Joly. “We made serious commitments to Canada when we acquired Stelco, and we have honoured them,…
In a report released today, Louise Chen from Scotiabank maintained a Buy rating on Pfizer, with a price target of $33.00. Chen covers the Healthcare sector, focusing on stocks such as AbbVie, Johnson & Johnson, and Amgen. According to TipRanks, Chen has…
Bausch + Lomb Corporation ( (BLCO) ) just unveiled an announcement. The most recent analyst rating on (BLCO) stock is a Buy with a $21.00 price target. To see the full list of analyst forecasts on Bausch + Lomb Corporation stock, see the BLCO Stock…
In a report released today, Akash Tewari from Jefferies maintained a Buy rating on Pfizer, with a price target of $36.00. According to TipRanks, Tewari is a 5-star analyst with an average return of 12.3% and a 57.29% success rate. Tewari covers the…
Operator: Good day, and welcome to the Acumen Pharmaceuticals Third Quarter 2026 Conference Call and Webcast. [Operator Instructions] Please note, this call may be recorded. I would now like to turn the call over to Alex Braun, Head of Investor Relations.
CPS assesses cardiac function by acquiring acoustic and electrical signals and analyzing them using artificial intelligence algorithms. CPS is designed to provide clinicians in almost any setting with pulmonary pressure assessments, without the need for invasive catheterization, to help identify…
SOUTH BOSTON, Va., Sept. 16, 2026 (GLOBE NEWSWIRE) -- IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) is pleased to announce that GenX™, its next-generation continuous HAMR™ titanium production platform, has been successfully validated through the first four production campaigns, completed on the commercial-scale…
After missing its target for Falcon business jet deliveries in 2025, Dassault is striving to cut production cycles, Chairman and CEO Eric Trappier said March 4. Dassault Falcon Output Undergoing Supply Chain, Internal Issues Thierry Dubois has specialized in aerospace journalism since…
US legacy automaker General MotorsGM delivered strong third-quarter 2026 results yesterday. Its earnings per share grew 32.2% year over year to $3.70 and topped the Zacks Consensus Estimate of $3.55. Revenues of $50.02 billion increased 3% year over year and outpaced the consensus mark of $48.21 billion.
Drug discovery, manufacturing, generics, patents, and commercialization pathways.
An article joins this feed when it matches these terms. Each one is also a search of its own.